Albertsons Opioid Trial Stalls As State Expert Admits He Can't Name One Improper Pill
Albertsons Opioid Trial Stalls As State Expert Admits He Can't Name One Improper Pill
By Foodie Pundit Newsroom - Published - Updated - Section: Grocery Cpg

Key points
- An economist representing Washington State conceded he cannot identify a single specific pill improperly dispensed by Albertsons, despite alleging 'red flags' in data.
- The case threatens the financial stability of one of the nation's largest food retailers, with potential multi-billion dollar implications.
- This litigation signals a shift toward holding grocery stores, not just drug makers, responsible for public health crises through the products they sell.
This report is part of Foodie Pundit premium coverage. Foodie Pundit members read the full story. See membership.
Sources and methodology
Reported from the public datasets below.
More from the Foodie Pundit Newsroom
- Spaghetti Chow Mein Is The New Pantry Raid Gold
- The Viral Crab Roast We Can't Stop Watching, Or Explaining
- The Internet's Perfect Omelette Is A Perfect Void
- Beyond the Lobster Tank: Bankruptcy, Endless Shrimp, and the End of an American Dining Era
- The End of Kitchen Waste: How Data Is Turning a Problem Into a Profit Center